BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32757171)

  • 1. Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).
    Grandone E; Aucella F; Barcellona D; Brunori G; Forneris G; Gresele P; Marietta M; Poli D; Testa S; Tripodi A; Genovesi S
    J Nephrol; 2021 Feb; 34(1):31-38. PubMed ID: 32757171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.
    Grandone E; Aucella F; Barcellona D; Brunori G; Forneris G; Gresele P; Marietta M; Poli D; Testa S; Tripodi A; Genovesi SC
    Blood Transfus; 2020 Nov; 18(6):478-485. PubMed ID: 33000751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XXV Congresso Nazionale della Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).
    Ageno W; Falanga A; Castaman G
    Blood Transfus; 2018 Nov; 16(Supplement no. 4):s415-s562. PubMed ID: 30412048
    [No Abstract]   [Full Text] [Related]  

  • 4. XXVI Congresso Nazionale della Società Italiana per lo Studio dell'Emostasi e della Trombosi - SISET, Baveno (VB), 5 - 7 novembre 2020.
    Tripodi A; Falanga A; De Stefano V
    Blood Transfus; 2020 Nov; 18(18 Suppl 4):. PubMed ID: 33155977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for the diagnosis and treatment of deep venous thrombosis. SIAPAV, SISET, SIDV-GIUV, CIF. Societaà Italiana di Angiologia e Patologia Vascolare, Società Italiana per lo Studio dell'Emostasi e Trombosi, Società Italiana di Diagnostica Vascolare, Collegio Italiano di Flebologia].
    Minerva Cardioangiol; 2000; 48(7-8):197-275. PubMed ID: 11089385
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.
    Ravera M; Bussalino E; Fusaro M; Di Lullo L; Aucella F; Paoletti E
    J Nephrol; 2020 Jun; 33(3):483-495. PubMed ID: 32200488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
    Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
    Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
    Stamellou E; Floege J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.
    Domienik-Karłowicz J; Tronina O; Lisik W; Durlik M; Pruszczyk P
    Cardiol J; 2020; 27(6):868-874. PubMed ID: 30912573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation.
    Makani A; Saba S; Jain SK; Bhonsale A; Sharbaugh MS; Thoma F; Wang Y; Marroquin OC; Lee JS; Estes NAM; Mulukutla SR
    Am J Cardiol; 2020 Jan; 125(2):210-214. PubMed ID: 31780073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.
    Zhang L; Steckman DA; Adelstein EC; Schulman-Marcus J; Loka A; Mathew RO; Venditti FJ; Sidhu MS
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):481-488. PubMed ID: 31165356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?].
    Di Lullo L; Magnocavallo M; Vetta G; Lavalle C; Barbera V; Ronco C; Paoletti E; Ravera M; Fusaro M; Russo D; De Pascalis A; Bellasi A
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease.
    Batra G; Modica A; Renlund H; Larsson A; Christersson C; Held C
    Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics.
    Baudo F; de Cataldo F; Mostarda G; Ghirarduzzi A; Molinatti M; Pengo V; Poli D; Tosetto A; Tiraferri E; Morra E
    Intern Emerg Med; 2007 Dec; 2(4):280-4. PubMed ID: 18046517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.